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Prenatal immunity to Plasmodium falciparum merozoite proteins involved in erythrocyte invasion may
contribute to the partial protection against malaria that is acquired during infancy in areas of stable malaria
transmission. We examined newborn and maternal cytokine and antibody responses to merozoite surface
protein-1 (MSP-1), ribosomal phosphoprotein P0 (PfP0), and region II of erythrocyte binding antigen-175
(EBA-175) in infant-mother pairs in Kenya. Overall, 82 of 167 (50%), 106 of 176 (60%), and 38 of 84 (45%) cord
blood lymphocytes (CBL) from newborns produced one or more cytokines in response to MSP-1, PfP0, and
EBA-175, respectively. Newborns of primigravid and/or malaria-infected women were more likely to have
antigen-responsive CBL than were newborns of multigravid and/or uninfected women at delivery. Newborn
cytokine responses did not match those of their mothers and fell into three distinct categories, Th1 (21 of 55
CBL donors produced only gamma interferon and/or interleukin 2 [IL-2]), Th2 (21 of 55 produced only IL-5
and/or IL-13), and mixed Th1/Th2 (13 of 55). Newborns produced more IL-10 than adults. High and low levels
of cord blood IL-12 p70 production induced by anti-CD40 activation were associated with malaria-specific Th1
and Th2 responses, respectively. Antigen-responsive CBL in some newborns were detected only after depletion
of IL-10-secreting CD8 cells with enrichment for CD4 cells. These data indicate that prenatal sensitization to
blood-stage Plasmodium falciparum occurs frequently in areas where malaria is holoendemic. Modulation of
this immunity, possibly by maternal parity and malaria, may affect the acquisition of protective immunity
against malaria during infancy.
Falciparum malaria places a high burden of health on preg-
nant women and infants in sub-Saharan Africa and other re-
gions of the world where malaria is endemic. Women experi-
encing their first pregnancies are especially vulnerable, and
their infants may be born prematurely and have low birth
weights (42). Maternal malaria and immunity may, however,
indirectly benefit young infants by enhancing resistance against
blood-stage infection and morbidity for the first several months
after birth. The best-understood mechanism underlying this
phenomenon involves immunoglobulin G (IgG) antibodies to
blood-stage Plasmodium falciparum. These antibodies are ac-
quired from the maternal circulation during gestation, target
merozoite invasion ligands and parasite antigens transported
to the surface of the infected erythrocyte, and presumably
protect the young infant from severe malaria and high-density
parasitemia by slowing the growth rate of intraerythrocytic
parasites (5, 8, 12). IgG antibodies of maternal origin decrease
progressively in the infant’s circulation and are completely lost
by 6 to 9 months after birth (12, 51, 59). A feature of maternal-
neonatal interaction that is not as well understood involves the
possible exposure of the fetus to malaria antigens in utero and
the consequent immunologic sensitization or tolerance this
may induce. The existence and nature of this prenatal immu-
nity may potentially have great significance, since T- and B-cell
memory and protective effector responses generally develop
after repeated bouts of malaria during infancy.
It is not possible to examine human fetal immunity to ma-
laria antigens in situ or determine directly whether in utero
exposure to malaria occurs. Nevertheless, several lines of evi-
dence suggest that such events occur, particularly in settings
where maternal malaria is common. First, infected maternal
erythrocytes have a propensity to be sequestered in the low-
flow intervillous space of the placenta (especially in primigrav-
idae) (2, 18, 24), thereby increasing the likelihood that infected
erythrocytes and soluble blood-stage antigens will gain access
to the fetal circulation. Second, newborns may be exposed to
malaria parasites at or shortly before parturition. Cord blood
infection rates of 5 percent or greater have been estimated on
the basis of microscopic inspection of cord blood from African
newborns (9, 20, 32, 57). Rates of 14 to 33 percent have been
reported when more-sensitive diagnostic methods, such as
PCR or circulating parasite antigen assays, are used (27, 28, 57,
61). Current evidence suggests that admixture of the maternal
and fetal circulations at the time the newborn is passing
through the birth canal is uncommon, since malaria genotypes
examined in matched cord and maternal blood samples are
often discordant with maternal peripheral blood (27, 28, 40,
57) or placental intervillous blood (27), and maternal IgE that
does not cross the placenta is rarely detected in cord blood
(30). Third, studies of rodent malarias demonstrate that pre-
natal T-cell sensitization occurs when pregnant rats are in-
fected with Plasmodium berghei (10, 11, 13–15). Lymphocytes
from newborn pups of malaria-infected dams proliferate in
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response to extracts of blood-stage parasites, and malaria-spe-
cific immunity can be adoptively transferred to naı¨ve rats by
lymphocytes from sensitized pups.
Sensitization of human newborns to malaria and other
blood-borne pathogens can be evaluated by studying antigen-
driven responses by cord blood lymphocytes (CBL), since these
cells reflect the pool of circulating fetal lymphocytes present at
birth. Cord blood IgM or IgE antibodies also constitute prima
facie evidence of in utero sensitization because, unlike IgG, the
previously mentioned Ig isotypes are not transferred across the
placenta from the maternal circulation. There have been rel-
atively few studies of human CBL responses to malaria anti-
gens (11, 19, 31, 50). Fievet and coworkers (19) observed that
9.8 and 13.2 percent of 164 Cameroonian newborns had CBL
gamma interferon (IFN-) and interleukin 4 (IL-4) responses
to native ring-infected erythrocyte surface antigen (RESA/
Pf155). Response rates to RESA antigenic peptides were sig-
nificantly lower, ranging from 1.3 to 6.3 percent.
We recently showed that antigenic peptides corresponding
to the C-terminal region of merozoite surface protein-1 (MSP-
1), a leading candidate for a human malaria vaccine, stimu-
lated CBL IFN- responses in 26 percent of 92 newborns from
an area of Kenya in which malaria is holoendemic (30). In
contrast, responses to the preerythrocytic P. falciparum antigen
liver stage antigen-1 were not detected, and CBL from control
newborns of mothers who had never been exposed to malaria
failed to respond to MSP-1, confirming the specificity of this
immunity for malaria. Importantly, lymphocytes from new-
borns that failed to respond to MSP-1 in bulk cultures pro-
duced IFN- when CD4 T cells were purified, suggesting that
prenatal sensitization to malaria may be more common than
that estimated by experiments using bulk CBL alone and that
a subset of neonatal lymphocytes may produce immunoregu-
latory cytokines that suppress IFN- and IL-2 production (19,
30, 50). In the current study, we examined maternal peripheral
blood mononuclear cell (PBMC), bulk CBL, and neonatal CD4
and CD8 T-cell cytokine responses to MSP-1 and two addi-
tional blood-stage antigens, P. falciparum ribosomal phospho-
protein P0 (PfP0) and erythrocyte binding antigen-175 (EBA-
175). T-cell cytokine profiles were correlated with evidence of
prenatal exposure to malaria antigens. In addition, we deter-
mined whether there is a bias toward malaria-driven Th2 cy-
tokine and increased IL-10 production by a subset of neonatal
CD4 T cells, as reported for other microbial antigens (1, 49).
MATERIALS AND METHODS
Study population. Healthy pregnant women living in a region of Coast Prov-
ince, Kenya, in which malaria is holoendemic were recruited from the antenatal
clinic at Msambweni District Hospital. Maternal venous blood and umbilical
cord blood from full-term newborns of uncomplicated pregnancies were col-
lected at the time of vaginal delivery. Blood samples from healthy adults and
newborns who had never been exposed to malaria were collected from 11 non-
pregnant residents of Cleveland, Ohio, and 20 healthy infants delivered vaginally
at University Hospitals of Cleveland. Ethical approval was obtained from the
Human Investigations Institutional Review Boards of University Hospitals of
Cleveland and the Kenya Medical Research Institute in Nairobi.
Of note, we were occasionally unable to perform all the described assays for all
individuals because of unavailability of some samples. This results in different
sample sizes for the different groups, although all assays were performed for the
majority of newborns and their mothers (n  90).
Determination of malaria infection status and in utero exposure to P. falci-
parum antigens. In addition to maternal and cord blood, intervillous blood for
the diagnosis of placental malaria was obtained by aspiration through a cannula
inserted into the maternal side of the placenta through the basal plate. For blood
smear diagnosis, thick and thin films were stained with 4 percent Giemsa and
examined microscopically for asexual P. falciparum organisms under 100 oil
immersion fields. For diagnosis by detection of circulating malaria antigen in
maternal peripheral, placental intervillous, and/or cord blood, histidine-rich pro-
tein-II (HRP-II) and malaria-specific lactate dehydrogenase (LDH) were mea-
sured with commercial kits (Cellabs Pty. Ltd., Brookvale, New South Wales,
Australia, and FlowLabs, Portland, OR, respectively). An individual was consid-
ered positive if circulating antigen was present, by one and/or both assays, in at
least one of the blood samples collected from the mother or her newborn. Plasma
separated from fresh blood was stored at 70°C until assays were performed
according to the manufacturer’s instructions.
PCR-based diagnosis of malaria. DNA was extracted from 200 l of whole
blood by use of individual spin blood kits (QIAGEN Inc., Valencia, CA). A
volume of 2.5 l of DNA was used for amplification of the multicopy 18S (small
subunit) rRNA genes of P. falciparum by real-time quantitative PCR as described
previously (23). PCR was performed using an ABI 3600 quantitative thermocy-
cler (GeneAmp 5700 sequence detector; ABI Research, Oyster Bay, NY). Each
run included no-template DNA (negative control) and 0.5-log-fold differences in
the estimated number of the small subunit rRNA amplicons (GenBank accession
no. AF145334) (positive control). The sensitivity of the real-time quantitative
PCR was between 10 and 20 P. falciparum-infected red blood cells/l.
Antigens and mitogens. Cytokine responses to three blood-stage antigens were
examined. Peptides corresponding to previously identified T-cell epitopes in the
C-terminal 83-kDa fragment of MSP-1, designated P2 (GYRKPLDNIKDNVG
KMEDYIKK; codons 250 to 271) and P3 (KLNSLNNPHNVLQNFSVFFNK;
codons 1101 to 1121), were synthesized by ResGen (Carlsbad, CA) and purified
to 95% (48). Three peptides corresponding to N- and C-terminal regions of
PfP0 were synthesized and purified to 70 to 80% (Chiron Corp., Clayton, Vic-
toria, Australia). The peptides were designated N1 (DNVGSNQMASVRKSLR;
codons 33 to 48), N2 (SVRKSLRGKATILMGKNT; codons 42 to 59), and C1
(AKADEPKKEEAKKVE; codons 285 to 299), and correspond to T-cell
epitopes identified by lymphocyte proliferation responses of immunized mice (6).
A purified GMP grade recombinant protein corresponding to region II of EBA-
175 (codons 144 to 753) was expressed in baculovirus (36) and kindly provided by
David Narum, Malaria Vaccine Development Unit, National Institutes of
Health, Bethesda, Md. Recombinant EBA-175 does not contain a tag used for
purification. Phorbol 12-myristate 13-acetate (PMA) plus ionomycin (Calbio-
chem, La Jolla, CA) were used as positive mitogen controls in parallel cultures.
Endotoxin in these preparations was 0.5 ng/ml; this concentration is 5- to
50-fold less than that required for lipopolysaccharide stimulation of cytokine
production by human lymphocytes.
Culture conditions and measurements of cytokine production by enzyme-
linked immunospot (ELISPOT) assay and enzyme-linked immunosorbent assay
(ELISA). All studies were performed with freshly isolated mononuclear cells/
lymphocytes separated from maternal venous (PBMC) or cord blood (CBL) by
density gradient centrifugation on Ficoll-Hypaque. After washing, cells were
finally suspended to a density of 2  106/ml to a total volume of 1 ml in RPMI
1640 supplemented with heat-inactivated 10% autologous plasma, 4 mM L-
glutamine, 25 mM HEPES, and 80 g/ml gentamicin (Biowhittaker, Gaithers-
burg, MD). In preliminary studies, heat-inactivated autologous plasma was not
suppressive compared to serum-free media in activated lymphocyte cultures
(data not shown). By contrast, we observed high background and nonspecific
lymphocyte reactivity by use of fetal calf serum or pooled human sera (data not
shown). Media alone (negative control), 10 g/ml MSP-1 P2 or P3 peptide, 10
g/ml PfP0 N1, N2, or C1 peptide, 5 g/ml EBA-175, and PMA (50 pg/ml) plus
ionomycin (1 g/ml) were added to duplicate wells in 0.5-ml cultures in 48-well
flat-bottomed plates (Costar) after optimal concentrations were determined in
pilot experiments.
The IFN- ELISPOT assay was performed at 48 h as described previously
(30). A positive response was scored when one of the following conditions was
met: (i) 4 IFN--secreting cells/106 PBMC or CBL were present in response to
recombinant EBA-175 plus similar responses to least one PfP0 or MSP-1 anti-
genic peptide when no IFN--secreting cells were present in negative-control
wells (media alone); (ii) 4 IFN--secreting cells were present in response to
two or more PfP0 or MSP-1 peptides when no IFN--secreting cells were present
in negative-control wells containing media alone; or (iii) in a case in which
IFN--secreting cells in negative-control wells were observed, the number of
spots generated by antigen-driven CBL was at least twofold greater. On the basis
of these criteria, no malaria antigen-driven IFN--secreting cells were detected
in CBL from 16 healthy North American newborns or PBMC from 10 malaria-
naı¨ve adults.
Quantification of IFN- and other cytokines by ELISA was performed on
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culture supernatants collected at 72 h. Results were expressed in pg/ml by
interpolation from standard curves based on recombinant lymphokines (29).
Antibody pairs for capture and detection (all biotinylated) for the cytokines
studied were as follows: for IL-5, 18051D and 18522D (BD-Pharmingen, San
Diego, CA); for IFN-, M-700A and M-701B (Endogen, Cambridge, MA); for
IL-13, P-130-E and M-130-B (Endogen); for IL-2, MAB-602 and BAF-202
(R&D Systems Inc., Minneapolis, MN); for IL-10, 18551D and 18652D (BD-
Pharmingen); and for tumor necrosis factor alpha (TNF-	), 18631D and 18642D
(BD-Pharmingen). A positive response was scored when the following two cri-
teria were fulfilled: (i) there was a net value for antigen-stimulated cells that was
at least twofold greater than that of parallel cultures containing media alone (if
cytokine production was not detectable in the negative-control cultures, then
40 pg/ml cytokine was considered to be a positive response) and (ii) there were
responses to two or more PfP0 or MSP-1 peptides or recombinant EBA-175 plus
one or more PfP0 or MSP-1 peptides.
Depletion and enrichment of CD4 and CD8 T cells. CBL were washed once,
and CD4 and CD8 T-cell enrichment was performed using magnetic beads
directly conjugated to anti-CD4 or anti-CD8 antibodies (Miltenyi Biotec, Au-
burn, CA). Immunomagnetic bead enrichment was performed according to the
manufacturer’s instructions. The purity of positively selected CD4 or CD8 T
cells was 95% (data not shown) ascertained by fluorescence-activated cell
sorter analysis. Autologous bulk CBL (105 cells/ml) were added as antigen-
presenting cells (APC) to purified CD4 or CD8 T cells (1.5  106/ml).
Preliminary studies demonstrated that autologous bulk APC produced malaria
antigen-driven cytokine responses similar to those of adherent cells as APC.
Anti-CD40-induced IL-12 production. Whole blood anticoagulated with 2
U/ml of sodium heparin was mixed with an equal volume of culture medium to
a total volume of 1 ml. Anti-CD40 monoclonal antibody (obtained from ATCC
HB-9110, clone G28-5) (33) was added at a concentration previously determined
to be optimal (16 g/ml), and incubation continued for 48 h. An identical amount
of mouse Ig isotype control (IgG1; Jackson ImmunoResearch, West Grove, PA)
was added to parallel cultures. ELISA was used to quantify IL-12 p70 production
(R&D Systems, Inc., Minneapolis, MN) by use of frozen supernatants.
IgM antibodies to MSP-119, PfP0, and EBA-175. IgM antibody to recombinant
MSP-119 expressed in Saccharomyces cerevisiae (Q-KNG variant; MR4, Be-
thesda, MD) was measured by ELISA as described previously (30). A similar
protocol was followed for measuring antibodies to recombinant PfP0 and EBA-
175 (22, 36). The recombinant PfP0 is a glutathione S-transferase (GST) fusion
protein. Therefore, all samples were run with GST alone. Optical densities were
recorded as that of the fusion protein minus that of GST alone. Briefly, Immu-
nolon 1 plates (Dynatech, Sterling, VA) were coated with 200 ng/ml of recom-
binant EBA-175 or 100 ng/ml PfP0 (22) in phosphate-buffered saline overnight
at 4°C. After being blocked and washed, freshly thawed plasma diluted to 1/100
was added, and incubation continued overnight at 4°C. The plates were then
washed, and alkaline phosphatase-conjugated anti-human IgM (Jackson Immu-
noResearch, Malvern, PA) diluted 1/2,000 was added for 1 h at room tempera-
ture. Substrate p-nitrophenyl phosphate (Sigma, St. Louis, MO) was added after
the final wash. The reaction was stopped by the addition of 5% EDTA, and
absorbance was read at 405 nm with a Vmax ELISA reader (Molecular Devices,
Sunnyvale, CA). Plasma samples from the North American adults and newborns
were used as controls.
Statistics. Cytokine data were log-normally distributed. The values were there-
fore expressed as geometric means 
 standard errors of the means, and statis-
tical tests were performed on log-transformed values. The significances of dif-
ferences between groups were evaluated by using Student’s t test, and
relationships between variables were examined by simple linear regression. Com-
parisons of the proportions of responders of various groups of donors were
evaluated by chi-square analysis.
RESULTS
Malaria infection of maternal, placental, and cord blood. P.
falciparum infection was diagnosed by blood smear, real-time
PCR, and malaria antigen immunoassay for the three blood
compartments examined (Fig. 1). As expected, PCR yielded a
higher proportion of positive tests than blood smear for each
of the blood compartments (2- to 5-fold greater). A second,
more striking finding emerged when the results were stratified
according to maternal parity. Samples from primigravidae had
higher infection rates than those from multigravidae regardless
of the blood compartment analyzed. For example, malaria
diagnosed by microscopic inspection of maternal blood smears
was observed for 18 percent of primigravidae, as opposed to 6
percent of multigravidae (P  0.02); cord blood smears from
the former group were also more frequently positive than
those from the latter group (P  0.01). Infection rates of
samples from cord blood of secundigravidae were intermedi-
ate. Blood smears positive by microscopy were concordant with
PCR results for maternal blood (81% of blood smear-positive
samples were also PCR positive) and placental blood (100%
agreement) but less so for cord blood (50% agreement). In-
fection status of cord blood determined by microscopy and
PCR was similar to that of maternal or placental blood, i.e.,
80% agreement when results of blood smear and PCR were
combined. PCR is more sensitive than blood smear analysis,
and it shows that malaria infections are diagnosed more com-
monly by PCR.
We also examined whether soluble malaria antigens released
into the circulation by infected erythrocytes were present by
measuring Plasmodium HRP-II and LDH (35, 47). Both anti-
gens were present more frequently in maternal and placental
blood from primigravidae than in blood from multigravidae
(Fig. 1). The presence of circulating malaria antigen in these
two blood compartments was 77% concordant with infection
diagnosed by blood smear or PCR. HRP-II and/or LDH was
also detected in 14 percent of cord blood samples from primi-
gravidae, as opposed to 6.7 percent of multigravidae. Concor-
dance of malaria antigen immunoassay and blood smear/PCR
results for cord blood was lower than for maternal venous and
placental blood (32% versus 77%). In sum, the results of blood
smear, PCR, and circulating antigen immunoassay demon-
strate that newborns of primigravidae are more likely those of
multigravidae to have prenatal exposure to malaria antigens.
Malaria antigen-specific cytokine responses by newborn and
maternal lymphocytes. Prenatal exposure to malaria-infected
erythrocytes or soluble malaria antigens may be associated
with immune responses in newborns. To determine this, we
first examined malaria antigen-stimulated IFN- CBL re-
FIG. 1. Maternal venous, placental, and cord blood infection sta-
tuses determined by blood smear (BS), real-time quantitative PCR
(RTQ-PCR), and detection of circulating malaria antigens (CAg). P.
falciparum infection was determined by microscopic inspection of
blood smear or real-time quantitative PCR and stratified according to
parity. Malaria-specific HRP-II and LDH in plasma were measured by
immunoassay as described in Materials and Methods. The numbers of
maternal venous blood samples of primigravid, secundigravid, and
multigravid donors analyzed were 79, 29, and 98, respectively; for
placental intervillous blood, the numbers of samples in each group
were 58, 26, and 82, respectively; and for cord blood samples, the
numbers of samples in each group were 74, 31, and 102, respectively.
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sponses by ELISPOT assay. The percentage of MSP-1-driven
responses by ELISPOT assay was the highest (74 of 169 donors
responded; 44%), followed by PfP0 (61 of 169; 36%) and
EBA-175 (39 of 132; 29%). The proportions of maternal
PBMC (obtained within 24 h of parturition) responding were
similar to those for newborns (42 of 116 [36%] for MSP-1, 55
of 116 [47%] for PfP0, and 30 of 114 [26%] for EBA-175).
Overall, 53 percent of newborns (89 of 169) and 57 percent of
mothers (66 of 116) had malaria-specific IFN--secreting lym-
phocytes to one or more of the three antigens tested. All CBL
and maternal PBMC preparations responded vigorously to
PMA plus ionomycin (data not shown).
Figure 2 shows the actual frequencies of IFN--secreting
cells by individual donors that responded to malaria blood-
stage antigen for both maternal and cord blood lymphocytes.
The geometric mean frequency of IFN--secreting lympho-
cytes was twofold greater for maternal PBMC than for CBL (P
 0.01). There was no correlation between the frequencies of
IFN--secreting cells for paired maternal PBMC and CBL (r2
 0.07; P  0.3), indicating that maternal lymphocytes were
unlikely to have contaminated cord blood.
In order to evaluate additional cytokines produced by CBL,
we measured IL-2, IL-13, IL-5, IL-10, TNF-	, and IFN- by
ELISA. Fifty-five of 170 CBL donors (32%) had malaria an-
tigen-driven responses. This lower frequency of cytokine pro-
duction in CBL as detected by ELISA is due to ELISA having
a lower sensitivity than the ELISPOT assay for detecting an-
tigen-specific responses (e.g., comparison of IFN- assays; data
not shown). When the results for IFN- ELISPOT assay and
all cytokine ELISAs were combined, 66 percent of CBL donors
were calculated to respond to one or more of the malaria
antigens.
Polarization of Th-cell cytokine responses. Figure 3 summa-
rizes the results for individual cytokines produced by CBL and
maternal PBMC. The lowest proportions and magnitudes of
CBL responses were for IL-5, IL-13, and IL-2 (response rates
were 10%), and the highest were for IL-10 (20, 18, and 25%
for MSP-1, PfP0, and EBA-175, respectively). The proportions
and magnitudes of IL-5, IL-13, IL-2, and IFN- responses by
maternal PBMC did not differ significantly from those by CBL.
In contrast, IL-10 responses by CBL were greater than those by
maternal PBMC (P  0.05), and TNF-	 responses by CBL
were lower than those by maternal PBMC in responses to
FIG. 2. CBL and maternal PBMC ELISPOT assay IFN- re-
sponses to malaria blood-stage antigens (Ag). Only the geometric
means and ranges of frequencies of IFN--secreting cells per 106 CBL
or maternal PBMC for individuals responding to MSP-1, PfP0 pep-
tides, and recombinant EBA-175 are shown. The maximum responses
to MSP-1 and PfP0 peptides are shown and were used to calculate the
geometric means. The proportion of newborns with IFN--secreting
cells was lower than that for their mothers (P  0.05 to 0.01). A total
of 169 CBL and 116 maternal PBMC donors were examined in re-
sponse to MSP-1 and PfP0 and 132 CBL and 114 PBMC in response
to EBA-175. The horizontal bars indicate the geometric means.
FIG. 3. The geometric mean levels of cytokine produced by posi-
tive responders to malaria antigens for CBL and maternal PBMC. The
percentages of individuals with a positive response for a given cytokine
are represented by the values immediately below each bar. Values are
in picograms/ml. A total of 170 CBL samples were evaluated for
responses to MSP-1 (A) and PfP0 (B); 90 CBL samples were evaluated
for responses to EBA-175 (C). Sixty-eight maternal PBMC samples
were evaluated for responses to all three antigens. Bars indicate the
geometric means 
 95% confidence intervals for CBL (solid bars) and
maternal PBMC (striped bars). An asterisk above a bar indicates a
significant difference between CBL and maternal PBMC, with one
asterisk (*) meaning that P was 0.05 and two asterisks (**) meaning
that P was 0.01. TNFa, TNF-	; IFN-g, IFN-.
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EBA-175 (P  0.05) and with a trend similar to those of MSP1
and PfP0. No North American control CBL (n  20) or adult
PBMC (n  11) cytokine responses to malaria antigens were
detected, although these preparations responded vigorously to
PMA plus ionomycin (data not shown).
Three patterns of Kenyan CBL and maternal PBMC cyto-
kine responses were discernible. Of the 55 antigen-reactive
CBL preparations (Fig. 4, upper panel), 21 (38%) produced
exclusively IFN- and/or IL-2, i.e., polarized Th1 response; 21
(38%) produced exclusively IL-5 and/or IL-13, i.e., polarized
Th2 response; and 13 (24%) had a mixed Th1/Th2 pattern.
IL-10 and TNF-	 responses were equally frequent for CBL
with a polarized Th1 or Th2 pattern. In contrast to CBL,
maternal PBMC (Fig. 4, upper panel) had a predominant Th1
cytokine response (60% of all donors) or mixed Th1/Th2 re-
sponse (29%). Malaria antigen-driven cytokine responses by
paired maternal and cord blood samples did not correlate with
each other (r2  0.13; P  0.21).
Predictors of cord blood Th-cell cytokine bias. To under-
stand the basis for the spectrum of cytokine responses ob-
served in newborns, we examined the relationship between
CBL cytokine pattern and evidence for prenatal exposure to
malaria. CBL from newborns with polarized Th1 responses
were twice as likely to have P. falciparum detectable in cord
blood by microscopy or PCR (12 of 21; 57%) relative to new-
borns with Th2 responses (6 of 21; 28.6%; chi-square  3.5; P
 0.07). This difference became statistically significant when
CBL that produced any Th1 cytokine response (mixed Th1/
Th2 patterns) were included in the Th1 group (20 of 34 for the
Th1 responders versus 6 of 21 for the Th2 responders; chi-
square  4.7; P  0.02).
We next analyzed the relationship between maternal parity
and CBL Th pattern. We reasoned that primigravidae would
be more likely than multigravidae to expose their fetuses to
malaria antigens during gestation, since the former are at a
higher risk of placental malaria (16, 17, 42). Sixty-seven and
sixty-two percent of newborns with exclusive Th1 or mixed
Th1/Th2 responses, as opposed to 24 percent with exclusive
Th2 responses, had primigravid mothers (Fig. 4, lower panel).
In contrast, this association was reversed for newborns of mul-
tigravid mothers: 51% had a polarized Th2 response and 19%
a Th1 response (P  0.05).
Enhanced IL-12 production by cord blood from newborns of
primigravidae. The observed spectrum of fetal cytokine re-
sponses may be due in part to differences in IL-12 production,
since this cytokine is critical to Th1 differentiation. For exam-
ple, immune cells of newborns are known to produce less IL-12
than those of adults (21) and are consequently less likely to
generate Th1 cytokines. Malaria infection of the fetus or trans-
placental passage of proinflammatory malaria molecules may
also prime CD40-expressing neonatal antigen-presenting cells
to produce IL-12, thereby favoring development of Th1-type
responses. Since there is no direct means of ascertaining ma-
laria infection or exposure to malaria antigens in utero
throughout pregnancy, we stratified cord blood IL-12 re-
sponses according to maternal parity and compared them to
those from whole blood obtained from the newborn’s mother.
Cord blood produced less IL-12 p70 than maternal blood
regardless of the mother’s parity. Cord blood from newborns
of primigravidae released significantly greater amounts of
IL-12 p70 than newborns of multigravidae (Fig. 5). Newborns
in the former group were also more likely to have a polarized
Th1 response (7 of 12 donors) than newborns in the latter
group (2 of 13 donors; chi-square  5.0; P  0.05). IL-12 p70
production was not detected in parallel cultures of maternal or
cord blood incubated with control mouse IgG1 (data not
shown).
Cord blood T-cell subsets contributing to cytokine produc-
tion. As a first step to determine the T-cell subsets that con-
tribute to or are required for cytokine production by neonatal
lymphocytes, CD4 and CD8 T cells were purified by positive
selection and antigen-driven cytokine production measured.
Sufficient cord blood lymphocytes were obtained from 15 new-
borns to examine T-cell-subset responses. The cord blood sam-
ples examined for T-cell-subset responses were similar in sev-
eral respects to samples that were not selected for subset
analysis; birth weights were similar, and the two groups had the
same proportion of mothers that were infected with malaria at
delivery and were primigravidae. Eight individuals produced
IL-10 and/or IFN- to one or more of the three malaria blood-
FIG. 4. Th-cell (Tc) cytokine pattern of malaria antigen (Ag)-
driven CBL and maternal PBMC responses and distribution of CBL
Th responses for newborns of primigravidae. Results of cytokine
ELISAs were categorized as Th1 type (IFN- and/or IL-2 only), Th2
type (IL-5 and/or IL-13 only), or mixed Th1/Th2 type (combinations of
the two groups). The percentages of CBL (solid bars) and maternal
PBMC (striped bars) donors with responses in a given category are
represented in the upper panel. The percentages of CBL donors of
primigravidae with a given Th pattern are shown in the lower panel.
The significance of differences between groups was evaluated using the
chi-square test. IFNg, IFN-.
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stage antigens tested (Fig. 6). There are two basic observations.
First, CD4 and not CD8 T cells produced IFN- in response
to the malaria antigens tested, whereas both CD4 and CD8
T cells secrete IL-10 in response to malaria antigens. Second,
both IFN- and IL-10 responses not detected in cultures of
bulk CBL were revealed when enriched CD4 and/or CD8 T
cells were incubated with malaria antigens. IL-2, IL-5, and
IL-13 were detected only in culture supernatants of enriched
CD4 T cells (data not shown).
Relationship of cord blood and maternal T-cell responses to
malaria infection and parity. Prenatal sensitization to malaria
antigens estimated by CBL cytokine responses was more likely
when P. falciparum infection coexisted in maternal peripheral
blood (76% of CBL samples from offspring of infected women
versus 38% from those of offspring of uninfected women; P 
0.001), placental intervillous blood (75% from samples from
offspring of women with placental malaria versus 41% of those
from offspring of woman without placental malaria; P 
0.001), and/or cord blood (80% of samples from offspring of
women with malaria infection versus 33% of those from off-
spring of women without infection; P  0.001). Similarly, ma-
laria-specific PBMC responses were detected more frequently
when maternal blood-stage infection coexisted (a frequency of
81% with concurrent malaria documented by smear or PCR
versus 30% for the women without concurrent malaria; P 
0.001). Primigravidae or secundigravidae were more likely to
have newborns with malaria-specific CBL cytokine responses
than multigravidae (35 of 104 [33.6%] versus 20 of 102
[19.6%]; chi-square  5.1; P  0.021).
Malaria-specific IgM antibody and its relationship to cord
blood cytokine responses. Maternal IgM does not normally
cross the human placenta and is thus presumed to originate
from fetal B cells when detected in cord blood. We assayed
plasma from cord blood for malaria-specific IgM antibodies. A
total of 6.6 percent of samples (5 of 75) contained IgM anti-
bodies to recombinant MSP-119 (Q-KNG variant, the most
common variant in the population [30]), 17.2 percent (21 of
122) contained these antibodies to PfP0, and 14.9 percent (22
of 147) contained these antibodies to EBA-175. A higher pro-
portion of maternal plasma samples had IgM antibodies: 16
percent (15 of 93), 61 percent (37 of 61), and 26 percent (36 of
138) had these antibodies to PfP0, EBA-175, and MSP-119,
respectively. The presences or levels of IgM antibodies in
paired maternal and newborn plasma samples did not correlate
with each other (r2  0.1; P  0.6). Newborns with IgM
antibodies tended to have CBL cytokine responses to the same
malaria antigens. Four of five with MSP-119-specific IgM anti-
body had MSP-1-driven CBL cytokine responses, 18 of 22
(82%) with PfP0-specific IgM had PfP0-driven cytokine re-
sponses, and 18 of 21 (76%) with EBA-175-specific IgM had
EBA-175-driven cytokine responses.
DISCUSSION
Results presented here show that prenatal T- and B-cell
immunity to P. falciparum blood-stage antigens commonly de-
velops in settings where malaria during pregnancy is a major
health problem. Sixty-six percent of the 176 Kenyan newborns
examined had CBL cytokine responses to MSP-1, PfP0, or
EBA-175, and 7 to 17 percent had IgM antibodies to the same
antigens. More than one-third of CBL cytokine responses had
an exclusive Th1 pattern, and one-third had a Th2 pattern that
differed from that of maternal PBMC, which were skewed
mainly to the Th1 pattern. Common features of newborn cy-
tokine responses were increased IL-10 production and dimin-
ished TNF-	 production, indicating an anti-inflammatory cy-
tokine bias by neonates. Consistent with this, newborns whose
CBL did not respond to malaria antigens in bulk culture had
detectable responses revealed after enrichment of the CD4
cells or CD8 T cells (Fig. 6), suggesting that active suppres-
sion or T-cell anergy to malaria develops prenatally in some
individuals.
Our observations support the concept that prenatal expo-
sure to maternal erythrocytes infected with P. falciparum or
soluble malaria antigens transported across the placenta oc-
curs with some regularity. Nine percent of cord blood samples
contained parasites detectable by blood smear or PCR, and
malaria-specific HRP-II and LDH were detected in plasma
samples from eight percent of cord blood donors. Other stud-
ies using a dual perfusion assay of the maternal and fetal
circulation with interposed viable human placenta have dem-
onstrated transplacental transfer of tetanus toxoid and ovalbu-
min (38, 39). CBL from newborns of mothers with evidence of
active malaria infection at parturition (by blood smear or
PCR) were also nearly twice as likely to contain malaria-re-
sponsive lymphocytes relative to CBL from newborns of moth-
ers without active malaria infection. Maternal infection ascer-
tained at a single time point (parturition) represents the
minimal likelihood of the unborn child being exposed to ma-
laria. We therefore attempted to estimate the malaria infection
status of these women during earlier periods of their pregnan-
cies. First, blood smears during earlier antenatal visits from
102 maternal participants were available. Fifteen (14.7%) were
positive for P. falciparum during the second or third trimester.
At parturition, 9 of these 15 women had negative blood smears
and PCR assays. Second, reasoning that primigravidae experi-
ence placental malaria more frequently than multigravidae
FIG. 5. Anti-CD40-induced IL-12 p70 production by maternal and
cord blood. Whole blood diluted 1:1 in culture medium was incubated
with 16 g/ml of cross-linking anti-CD40 for 48 h. Supernatants were
harvested, and IL-12 p70 was measured by ELISA. Bars represent
means 
 standard deviations. Significant differences were determined
by Student’s t test. Five of the cord blood samples from primigravid
women had evidence of malaria infection based on blood smear (n 
1), PCR (n  2), or HRP-II/LDH (n  2). Cord blood from one
multigravida had evidence of malaria by PCR.
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(41), we assessed the relationship between parity and CBL
cytokine responses. Newborns of primigravidae and secundi-
gravidae were more likely to have malaria-specific CBL re-
sponses than multigravidae (33.6% versus 19.6%).
The spectrum of cytokines generated by neonates differed
from that of their mothers. Maternal PBMC produced mostly
IFN- and IL-2, indicative of a Th1 pattern. In contrast, new-
born lymphocytes were less likely to produce IFN- and IL-2
and instead had a propensity to produce solely IL-5 and IL-13,
indicative of a Th2 response. Our studies did not include non-
pregnant Kenyan women and men, so we do not yet know
whether responses by these groups are different from those of
women in the third trimester of pregnancy. CBL of newborns
from areas where malaria is not endemic have previously been
shown to have preferential Th2 responses to exogenous anti-
gens due, in part, to depressed IL-12 production by antigen-
presenting cells which drive Th1 differentiation (34, 60).
To begin to understand why a subset of neonates expressed
malaria-specific Th1 as opposed to Th2 cytokines, we assessed
the relationship between Th-cell cytokine bias and presump-
tive prenatal exposure to malaria. Newborns of uninfected and
multigravid mothers, i.e., pregnant women anticipated to have
relatively light malaria burdens during pregnancy, were more
likely to have CBL IL-5 and IL-13 responses. Although many
of these women and their offspring were uninfected at birth, it
is likely that many had malaria infections earlier during preg-
nancy to allow sufficient amounts of malaria antigen to cross
the placenta and have exposure to the fetus. By contrast, off-
spring of malaria-infected and primigravid/secundigravid
mothers, i.e., groups anticipated to have heavier malaria bur-
dens during pregnancy, were likely to have IFN- and IL-2
responses. These associations suggest that the magnitude of
fetal exposure to infected erythrocytes or their soluble blood-
stage antigens may regulate, in part, whether the fetus acquires
a Th1- or Th2-type response to blood-stage antigens. With
heavier infections during pregnancy, infected erythrocytes may
cross the placenta, resulting in the release of malaria toxins in
addition to malaria antigens (53). In this regard, proinflamma-
tory Plasmodium glycosylphosphatidylinositol molecules (54)
might favor the differentiation of fetal antigen-presenting cells
to produce IL-12. In support of this, we found that the level of
IL-12 produced by cord blood incubated with anti-CD40,
which activates CD40 expressed on dendritic cells and mono-
cytes, was greater for newborns with evidence of prenatal in-
fection and/or of primigravidae than for newborns without
evidence of prenatal infection and/or of multigravidae. Fur-
ther, robust IL-12 responses correlated with CBL IL-2/IFN-
production, whereas weak IL-12 responses correlated with IL-
5/IL-13 production. Results of recent studies of Gambian new-
borns (25) are broadly similar to those reported here in that
FIG. 6. Malaria antigen-driven IL-10 and IFN- by bulk CBL and enriched CD4 and CD8 T cells. CBL were cultured at 2  106/ml in a
volume of 1 ml in 48-well culture plates with or without antigen for 72 h as described in Materials and Methods. Parallel cultures of CD4 and
CD8 T cells (enriched by immunomagnetic positive selection) at a cell concentration of 1.5 106/ml with 1 105 bulk CBL as antigen-presenting
cells were performed. Each symbol represents the levels of peak net antigen-driven cytokine production (antigen  spontaneous) for the same
individual for both cytokines (n  8).
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both suggest that exposure to malaria antigens in utero affects
the innate response as well as the adaptive immune response.
There are, however, several differences between the two stud-
ies. The Gambian data showed that lipopolysaccharide in-
duced less IL-12 p40 production by cord blood cells from
newborns of women with placental malaria than those of
women without placental malaria. These findings were inter-
preted to indicate that malaria-infected erythrocytes suppress
IL-12 responses by fetal antigen-presenting cells (58). Several
factors might account for differences between the Gambian
and Kenyan data. First, the production of the IL-12 p40 sub-
unit may not parallel that of the p70 subunit, particularly in the
case of neonates in whom the p35 subunit is deficient (21).
Malaria antigen-driven IL-10 responses were observed more
frequently for newborn than maternal lymphocytes. Polyclonal
activation of newborn T cells has been shown previously to
lead to greater production of IL-10 than that of adult T cells (4,
49), indicating a greater intrinsic ability to produce this cyto-
kine. IL-10 might be produced by regulatory lymphocytes,
such as CD4 IL-10hi TGF-hi IFN-low cells (52), natural
CD4CD25 regulatory cells (46, 55), or antigen-responsive
CD8 T cells. This possibility is supported by experiments that
revealed antigen-responsive cells in bulk CBL only after en-
richment of various lymphocyte subsets (Fig. 6).
The malaria blood-stage antigens studied here are thought
to be involved in merozoite invasion of erythrocytes. Protein
domains of MSP-1 and EBA-175 are currently being consid-
ered for vaccine strategies. The C-terminal 19-kDa portion of
MSP-1 is one of several possible targets of invasion-inhibitory
antibodies in vivo (3, 26, 43). The MSP-1 T-cell epitopes used
in the current study are contained in the 83-kDa portion of
MSP-1 that is processed prior to the appearance of the mem-
brane-anchored 19-kDa fragment which is ultimately carried
into the newly infected erythrocyte (48). Neonatal T-cell re-
sponses to this region of MSP-1 have not, to our knowledge,
been examined. Region II of EBA-175 contains motifs in-
volved in binding to glycophorin A on the erythrocyte surface
(56). Epidemiological studies have shown that antibodies to
EBA-175 correlate inversely with age-related changes in par-
asitemia (44). T-cell responses to region II of EBA-175 in
malaria-infected adults or newborns of malaria-exposed preg-
nant women have not been previously reported. PfP0 is the
least studied of the three antigens. The protein is expressed on
the merozoite surface and polyclonal antibodies to its N- and
C-terminal domains inhibit P. falciparum growth in vitro (6, 7).
Naturally acquired antibodies to PfP0 in adults residing in
areas of India and Africa in which malaria is endemic are
detectable (37). This report is the first to describe T-cell re-
sponses to PfP0 in humans. These responses were on average
higher than those stimulated by MSP-1 and EBA-175.
In conclusion, the data presented here demonstrate that
newborns from an area of Kenya where malaria is holoendemic
are commonly sensitized to blood-stage antigens in utero. The
presence and cytokine pattern of this immunity is not uniform,
exhibiting a pattern indicative of a predominant Th1 or Th2
immunity that correlates with maternal malaria and parity.
Future work to understand the mechanisms involved in regu-
lating the expression of neonatal immunity to malaria and the
risk factors that influence these outcomes needs to be directed
at defining the neonatal T-cell regulatory subsets and antigen-
presenting cell maturation pathways affected by maternal and
placental malaria. These studies should not only advance un-
derstanding of the immune basis of the heterogeneity of infant
malaria susceptibility but also be highly relevant to the evalu-
ation and deployment of childhood malaria vaccines.
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